Flecainide acetate and Diverticulitis - a phase IV clinical study of FDA data

Summary:

Diverticulitis is reported as a side effect among people who take Flecainide acetate (flecainide acetate), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Coumadin, and have Breast cancer female.

The phase IV clinical study analyzes which people have Diverticulitis when taking Flecainide acetate. It is created by eHealthMe based on reports of 6,177 people who have side effects when taking Flecainide acetate from the FDA, and is updated regularly.

What is Flecainide acetate?

Flecainide acetate has active ingredients of flecainide acetate. It is often used in atrial fibrillation/flutter. eHealthMe is studying from 7,176 Flecainide acetate users. Check the latest studies of Flecainide acetate.

What is Diverticulitis?

Diverticulitis (digestive disease which involves the formation of pouches (diverticula) within the bowel wall) is found to be associated with 1,362 drugs and 1,360 conditions by eHealthMe. Check the latest studies of Diverticulitis.

On Jul, 18, 2026

6,177 people reported to have side effects when taking Flecainide acetate.
Among them, 14 people (0.23%) have Diverticulitis.

Could Flecainide acetate cause Diverticulitis?

Among these 14 people:

How long have people been on Flecainide acetate when they have Diverticulitis? *

What is the gender of people who have Diverticulitis when taking Flecainide acetate? *

female: 78.57 %
male: 21.43 %

What is the age of people who have Diverticulitis when taking Flecainide acetate? *

What are other drugs people take besides Flecainide acetate? *

What are other side effects people have besides Diverticulitis? *

Ocular Discomfort (a generic expression when there is lack of ease in/about the eyes): 4 people, 28.57%
Diarrhea: 4 people, 28.57%
Eye Pruritus (eye itching): 4 people, 28.57%
Blood Potassium Decreased: 4 people, 28.57%
Dry Eyes (lack of adequate tears): 4 people, 28.57%
Fatigue (feeling of tiredness): 3 people, 21.43%
Dyspnea (difficult or laboured breathing): 3 people, 21.43%
Lacrimation Increased: 3 people, 21.43%
Dizziness: 3 people, 21.43%
Visual Impairment: 3 people, 21.43%

What are the existing conditions these people have? *

Pulmonary Hypertension (increase in blood pressure in the lung artery): 2 people, 14.29%
Psoriasis (immune-mediated disease that affects the skin): 2 people, 14.29%
Hypersensitivity: 2 people, 14.29%
Breast Cancer Female: 2 people, 14.29%
Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 1 person, 7.14%
Paroxysmal Arrhythmia: 1 person, 7.14%
Breast Cancer: 1 person, 7.14%

* Approximation only. Some reports may have incomplete information.

Do you take Flecainide acetate and have Diverticulitis?

- Check whether Diverticulitis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Flecainide acetate:

Flecainide acetate (7,176 reports)

Diverticulitis treatments and more:

Diverticulitis (38,782 reports)

Browse all side effects of Flecainide acetate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Diverticulitis:

Diverticulitis (1,362 drugs)

Browse all the conditions that are associated with Diverticulitis:

Diverticulitis (1,360 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on flecainide acetate (the active ingredients of Flecainide acetate) and Flecainide acetate (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.